ASSET | DATE | % RETURN |
---|---|---|
Amerant Bancorp (AMTB) | 8/20/2018 - 12/24/2018 | 4,124,100% |
Immatics (IMTX) | 8/20/2018 - 12/24/2018 | 193,500% |
Reliance Global (RELI) | 8/20/2018 - 12/24/2018 | 2,056.86% |
Osisko Development (ODV) | 8/20/2018 - 12/24/2018 | 2,024.1% |
NioCorp Developments Ltd Common Stock (NB) | 8/20/2018 - 12/24/2018 | 780% |
Castellum (CTM) | 8/20/2018 - 12/24/2018 | 366.67% |
Amarin (AMRN) | 8/20/2018 - 12/24/2018 | 319.26% |
American Resources Corp Class A (AREC) | 8/20/2018 - 12/24/2018 | 242% |
CorMedix (CRMD) | 8/20/2018 - 12/24/2018 | 181.32% |
CEL-SCI (CVM) | 8/20/2018 - 12/24/2018 | 137.9% |
Energy of Minas Gerais Co DRC (CIG.C) | 8/20/2018 - 12/24/2018 | 137.54% |
TNF Pharmaceuticals (TNFA) | 8/20/2018 - 12/24/2018 | 137.22% |
Tilray (TLRY) | 8/20/2018 - 12/24/2018 | 126.96% |
Serina Therapeutics (SER) | 8/20/2018 - 12/24/2018 | 126.54% |
Oragenics (OGEN) | 8/20/2018 - 12/24/2018 | 109.76% |
AGM Group Holdings Inc Class A (AGMH) | 8/20/2018 - 12/24/2018 | 101.31% |
ProQR Therapeutics (PRQR) | 8/20/2018 - 12/24/2018 | 100.66% |
Gravity (GRVY) | 8/20/2018 - 12/24/2018 | 100% |
SS Innovations International Inc Common Stock (SSII) | 8/20/2018 - 12/24/2018 | 99.33% |
Intrusion (INTZ) | 8/20/2018 - 12/24/2018 | 94.36% |
Lixte Biotechnology (LIXT) | 8/20/2018 - 12/24/2018 | 90.76% |
Atlanticus (ATLC) | 8/20/2018 - 12/24/2018 | 87.03% |
Skye Bioscience, Inc Common Stock (SKYE) | 8/20/2018 - 12/24/2018 | 77.5% |
Pacific Biosciences of California (PACB) | 8/20/2018 - 12/24/2018 | 75.66% |
Uxin (UXIN) | 8/20/2018 - 12/24/2018 | 75.42% |